Barrington Research Weighs in on Cross Country Healthcare, Inc.’s Q2 2022 Earnings (NASDAQ:CCRN)

Cross Country Healthcare, Inc. (NASDAQ:CCRNGet Rating) – Analysts at Barrington Research issued their Q2 2022 earnings per share (EPS) estimates for shares of Cross Country Healthcare in a research note issued to investors on Monday, April 11th. Barrington Research analyst K. Steinke anticipates that the business services provider will post earnings of $1.03 per share for the quarter. Barrington Research also issued estimates for Cross Country Healthcare’s FY2022 earnings at $3.98 EPS and FY2023 earnings at $3.16 EPS.

Cross Country Healthcare (NASDAQ:CCRNGet Rating) last announced its quarterly earnings results on Wednesday, February 23rd. The business services provider reported $1.40 EPS for the quarter, beating the Zacks’ consensus estimate of $1.35 by $0.05. Cross Country Healthcare had a net margin of 7.87% and a return on equity of 52.08%. The company had revenue of $640.68 million for the quarter, compared to analysts’ expectations of $611.54 million. During the same period in the prior year, the company posted $0.19 EPS. Cross Country Healthcare’s revenue was up 197.2% compared to the same quarter last year.

Other analysts have also recently issued reports about the stock. Zacks Investment Research upgraded shares of Cross Country Healthcare from a “hold” rating to a “strong-buy” rating and set a $22.00 target price on the stock in a research note on Friday, January 21st. Benchmark increased their target price on shares of Cross Country Healthcare from $33.00 to $42.00 and gave the stock a “buy” rating in a research note on Thursday, February 24th. Jefferies Financial Group raised shares of Cross Country Healthcare from a “hold” rating to a “buy” rating and increased their price target for the stock from $18.00 to $27.00 in a report on Thursday, January 27th. Finally, StockNews.com initiated coverage on shares of Cross Country Healthcare in a report on Thursday, March 31st. They issued a “hold” rating on the stock. Two analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, Cross Country Healthcare presently has a consensus rating of “Buy” and a consensus price target of $28.14.

NASDAQ CCRN opened at $21.30 on Thursday. Cross Country Healthcare has a 1 year low of $12.47 and a 1 year high of $30.40. The company has a debt-to-equity ratio of 0.59, a current ratio of 2.54 and a quick ratio of 2.54. The stock has a market capitalization of $810.68 million, a PE ratio of 6.03, a P/E/G ratio of 1.10 and a beta of 1.06. The company’s 50 day simple moving average is $21.33 and its two-hundred day simple moving average is $22.86.

Institutional investors have recently made changes to their positions in the business. Koshinski Asset Management Inc. purchased a new stake in shares of Cross Country Healthcare in the 4th quarter worth about $74,000. Advisor Group Holdings Inc. lifted its position in shares of Cross Country Healthcare by 492.6% in the 4th quarter. Advisor Group Holdings Inc. now owns 2,963 shares of the business services provider’s stock worth $82,000 after purchasing an additional 2,463 shares during the period. Crossmark Global Holdings Inc. purchased a new stake in shares of Cross Country Healthcare in the 3rd quarter worth about $100,000. Spire Wealth Management lifted its position in shares of Cross Country Healthcare by 490.0% in the 3rd quarter. Spire Wealth Management now owns 5,900 shares of the business services provider’s stock worth $125,000 after purchasing an additional 4,900 shares during the period. Finally, Royal Bank of Canada lifted its position in shares of Cross Country Healthcare by 106.7% in the 2nd quarter. Royal Bank of Canada now owns 8,860 shares of the business services provider’s stock worth $147,000 after purchasing an additional 4,574 shares during the period. 90.96% of the stock is currently owned by institutional investors and hedge funds.

In other Cross Country Healthcare news, CFO William J. Burns sold 10,000 shares of the firm’s stock in a transaction on Monday, March 7th. The shares were sold at an average price of $20.54, for a total value of $205,400.00. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, General Counsel Susan E. Ball sold 17,458 shares of the firm’s stock in a transaction on Monday, March 7th. The stock was sold at an average price of $20.72, for a total transaction of $361,729.76. The disclosure for this sale can be found here. 5.60% of the stock is currently owned by company insiders.

Cross Country Healthcare Company Profile (Get Rating)

Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company operates in two segments, Nurse and Allied Staffing and Physician Staffing. The Nurse and Allied Staffing segment offers traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, local nurses, and allied staffing; staffing solutions for registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and clinical and non-clinical professionals on long-term contract assignments, as well as workforce solutions, including MSP, RPO, and consulting services.

Featured Stories

Earnings History and Estimates for Cross Country Healthcare (NASDAQ:CCRN)

Receive News & Ratings for Cross Country Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.